Dementia Research and the Innovative Medicines Initiative

MOPEAD is one of a number of projects focusing on Alzheimer’s disease and dementia that are funded by the Innovative Medicines Initiative (IMI). In this article, Elisabetta Vaudano, IMI Principal Scientific Officer, outlines some of the challenges in finding a cure for Alzheimer’s disease and how collaboration helps tackle them.

Read the full article here.

Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations